We are live on ! Find out more
CRDF icon

Cardiff Oncology
CRDF

116 hedge funds and large institutions have $39.7M invested in Cardiff Oncology in 2026 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 30 increasing their positions, 37 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

908% more call options, than puts

Call options by funds: $1.19M | Put options by funds: $118K

69% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 13

5% more funds holding

Funds holding: 110 → 116 (+6)

4.49% less ownership

Funds ownership: 40.45% → 35.96% (-4.5%)

19% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 37

48% less capital invested

Capital invested by funds: $76.6M → $39.7M (-$36.8M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
116
Holders Change
+6
Holders Change %
+5.45%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
22
Increased
30
Reduced
37
Closed
13
Calls
$1.19M
Puts
$118K
Net Calls
+$1.07M
Net Calls Change
-$724K

Top Buyers

1
UBS Group
UBS Group
Switzerland
+$643K
2
Renaissance Technologies
Renaissance Technologies
New York
+$208K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$157K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$145K
5
AQR Capital Management
AQR Capital Management
Connecticut
+$136K

Top Sellers

1
William Blair & Company
William Blair & Company
Illinois
-$2.11M
2
Two Sigma Investments
Two Sigma Investments
New York
-$1.06M
3
CS
Candriam SCA
Luxembourg
-$968K
4
Goldman Sachs
Goldman Sachs
New York
-$512K
5
ACA
Acorn Capital Advisors
New York
-$411K
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
76
Integrity Alliance
Iowa
$20.8K – – –
PI
77
PFG Investments
New York
$20.3K – – –
TRCT
78
Tower Research Capital (TRC)
New York
$19.8K +$12.8K +6,257 +104%
RS
79
R Squared
Hong Kong
$19.1K -$1.85K -899 -7%
VOYA Investment Management
80
VOYA Investment Management
Georgia
$19K -$1.66K -810 -6%
Barclays
81
Barclays
United Kingdom
$18.9K -$179K -87,197 -88%
LWA
82
Ledgewood Wealth Advisors
New Hampshire
$18.1K – – –
SA
83
Scarborough Advisors
Maryland
$17K – – –
SG Americas Securities
84
SG Americas Securities
New York
$16K -$11.8K -5,741 -36%
SNB
85
Security National Bank
Nebraska
$15.8K – – –
TCOT
86
Trust Company of Toledo
Ohio
$14.6K +$18.5K +9,000 New
Legal & General Group
87
Legal & General Group
United Kingdom
$9.25K -$978 -476 -8%
AIP
88
Ameritas Investment Partners
Nebraska
$9.2K – – –
Russell Investments Group
89
Russell Investments Group
United Kingdom
$8.32K – – –
Royal Bank of Canada
90
Royal Bank of Canada
Ontario, Canada
$8K +$7.14K +3,477 +202%
New York State Common Retirement Fund
91
New York State Common Retirement Fund
New York
$5.83K – – –
California State Teachers Retirement System (CalSTRS)
92
California State Teachers Retirement System (CalSTRS)
California
$5.43K -$947 -461 -12%
US Bancorp
93
US Bancorp
Minnesota
$5.04K – – –
Carson Wealth (CWM LLC)
94
Carson Wealth (CWM LLC)
Nebraska
$4.92K +$5.23K +2,545 +514%
EP
95
Essential Partners
California
$4.16K +$5.27K +2,567 New
Federated Hermes
96
Federated Hermes
Pennsylvania
$3.65K +$4.63K +2,253 New
HC
97
Hurley Capital
New York
$3.4K -$10.3K -5,000 -70%
Optiver Holding
98
Optiver Holding
Netherlands
$2.68K +$3.4K +1,657 New
SCM
99
Sterling Capital Management
North Carolina
$2.07K -$2.42K -1,179 -48%
GI
100
GAMMA Investing
California
$1.99K +$992 +483 +65%
2 3
4
5 6

CRDF Hedge Fund Activity: Q1 2026 in Review

116 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q1 2026, worth a combined $39.7M — down 48% from $76.6M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new CRDF positions and 13 closed out — a net gain of 9 holders — while 30 added to existing stakes and 37 trimmed.

The largest buyer was UBS Group, adding an estimated $643K. The largest seller was William Blair & Company, cutting an estimated $2.11M.

  • 116 institutional investors held Cardiff Oncology (CRDF) as of Q1 2026, up from 110 in Q4 2025.
  • Funds reported $39.7M of Cardiff Oncology stock for Q1 2026, down 48% quarter-over-quarter.
  • 22 funds opened new Cardiff Oncology positions in Q1 2026 and 13 closed out, a net change of +9 holders.
  • The largest Cardiff Oncology buyer in Q1 2026 was UBS Group, an estimated $643K added.
  • The largest Cardiff Oncology seller in Q1 2026 was William Blair & Company, an estimated $2.11M sold.

Based on aggregated 13F filings for Q1 2026.